StockNews.com upgraded shares of Pro-Dex (NASDAQ:PDEX – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday.
Pro-Dex Stock Up 13.8 %
PDEX opened at $26.49 on Friday. Pro-Dex has a 52 week low of $14.51 and a 52 week high of $27.60. The company has a quick ratio of 1.66, a current ratio of 2.84 and a debt-to-equity ratio of 0.24. The firm has a 50-day simple moving average of $19.89 and a two-hundred day simple moving average of $18.94. The company has a market capitalization of $88.99 million, a PE ratio of 45.66 and a beta of 0.38.
Pro-Dex (NASDAQ:PDEX – Get Free Report) last released its quarterly earnings results on Thursday, September 5th. The medical instruments supplier reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.11. The business had revenue of $15.03 million during the quarter. Pro-Dex had a return on equity of 6.82% and a net margin of 3.95%.
Insider Buying and Selling at Pro-Dex
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the company. Perritt Capital Management Inc. boosted its stake in shares of Pro-Dex by 43.3% during the 1st quarter. Perritt Capital Management Inc. now owns 6,000 shares of the medical instruments supplier’s stock worth $106,000 after purchasing an additional 1,813 shares during the period. Renaissance Technologies LLC lifted its stake in Pro-Dex by 7.9% in the second quarter. Renaissance Technologies LLC now owns 12,240 shares of the medical instruments supplier’s stock worth $240,000 after purchasing an additional 900 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Pro-Dex by 5.1% during the second quarter. Dimensional Fund Advisors LP now owns 63,036 shares of the medical instruments supplier’s stock valued at $1,238,000 after buying an additional 3,067 shares during the period. Institutional investors own 15.28% of the company’s stock.
Pro-Dex Company Profile
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Stories
- Five stocks we like better than Pro-Dex
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why Block’s Key Components Make It a Solid Investment Choice
- Trading Halts Explained
- Is Applied Digital’s Stock Set to Surge With NVIDIA’s Backing?
- ESG Stocks, What Investors Should Know
- 4 Reasons to Consider Adding General Mills to Your Portfolio
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.